Pacific Edge keeps throwing cash at US push

Pacific Edge keeps throwing cash at US push
David Darling: US remains the core focus. (Image: supplied)
Staff reporters
Cancer diagnostics company Pacific Edge posted a loss of $9 million for the half year ended September 30, after expenses increased to $15.7m, up $4.5m on the comparable 2020 period.The company posted a loss for the September 2020 period of $7.1m, which widened to $14.2m by March. Chief executive David Darling said the higher operating costs reflected accelerated spending into growth areas, particularly into sales and marketing efforts in its key US market. That saw 16 new hires during the six months to a total of 28 employees in its U...